Yue-zhong Wu

Guido Marcucci, Stefano Volinia, Jessica Kohlschmidt, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Suppression of the protein tyrosine phosphatase receptor type O gene (PTPRO) by methylation in hepatocellular carcinomas

Yue-zhong Wu, C. Plass, K. Ghoshal, 2003, Oncogene.

Global assessment of promoter methylation in a mouse model of cancer identifies ID4 as a putative tumor-suppressor gene in human leukemia

Wei Ding, Guido Marcucci, Christoph Plass, 2005, Nature Genetics.

CpG Island Methylation in a Mouse Model of Lymphoma Is Driven by the Genetic Configuration of Tumor Cells

Sandya Liyanarachchi, Benjamin Keller, Michael C. Ostrowski, 2007, PLoS genetics.

Comparative Evaluation of Prognostic Factors That Assess the Natural History of Chronic Lymphocytic Leukemia

J. Byrd, Yue-zhong Wu, L. Rassenti, 2016 .

An AscI boundary library for the studies of genetic and epigenetic alterations in CpG islands.

Dieter Weichenhan, Christoph Plass, Ramana V Davuluri, 2002, Genome research.

Solasonine promotes ferroptosis of hepatoma carcinoma cells via glutathione peroxidase 4-induced destruction of the glutathione redox system.

Yue-zhong Wu, Gang Huang, Chunzi Shi, 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Hsa_circ_0001944 promotes the growth and metastasis in bladder cancer cells by acting as a competitive endogenous RNA for miR-548

Yue-zhong Wu, Shengjie Lu, Chunzi Shi, 2020, Journal of Experimental & Clinical Cancer Research.

Identification of novel methylation markers in cervical cancer using restriction landmark genomic scanning.

Kathleen R. Cho, Yue-zhong Wu, C. Plass, 2008, Cancer research.

Restriction Landmark Genomic Scanning (RLGS) spot identification by second generation virtual RLGS in multiple genomes with multiple enzyme combinations

R. Wenger, Yue-zhong Wu, C. Plass, 2007, BMC Genomics.

Sp1/NF κ B/HDAC/ miR-29b Regulatory Network in KIT-driven Myeloid Leukemia

M. Caligiuri, C. Bloomfield, J. Byrd, 2010 .

A NotI-EcoRV promoter library for studies of genetic and epigenetic alterations in mouse models of human malignancies.

M. Caligiuri, Yue-zhong Wu, C. Plass, 2004, Genomics.

Lenalidomide-mediated enhanced translation of C/EBPα-p30 protein up-regulates expression of the antileukemic microRNA-181a in acute myeloid leukemia.

M. Caligiuri, C. Bloomfield, J. Byrd, 2013, Blood.

MicroRNA-204-5p is a tumor suppressor and potential therapeutic target in head and neck squamous cell carcinoma

Yue-zhong Wu, Xiqiang Liu, Cheng Wang, 2020, Theranostics.

BAALC and ERG expression levels are associated with outcome and distinct gene and microRNA expression profiles in older patients with de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.

M. Caligiuri, C. Bloomfield, M. Radmacher, 2010, Blood.

miR-3151 interplays with its host gene BAALC and independently affects outcome of patients with cytogenetically normal acute myeloid leukemia.

M. Caligiuri, C. Bloomfield, M. Radmacher, 2012, Blood.

inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations.

M. Caligiuri, C. Bloomfield, Yue-zhong Wu, 2013, Blood.

ASXL1 mutations identify a high-risk subgroup of older patients with primary cytogenetically normal AML within the ELN Favorable genetic category.

M. Caligiuri, C. Bloomfield, M. Radmacher, 2011, Blood.

Prognostic significance of the European LeukemiaNet standardized system for reporting cytogenetic and molecular alterations in adults with acute myeloid leukemia.

C. Bloomfield, Yue-zhong Wu, K. Metzeler, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Structural characterization of Rasgrf1 and a novel linked imprinted locus.

Yue-zhong Wu, C. Plass, G. Leone, 2002, Gene.

Screening for hub genes and signaling pathways of CD8+ T cells in systemic lupus erythematosus using bioinformatics

Yue-zhong Wu, 2021, E3S Web of Conferences.

Identification and verification of the potential effect of therapeutic miRNA-mRNA pairs on ferroptosis in small cell lung cancer by bioinformatics analysis

Yue-zhong Wu, 2021, bioRxiv.

Low expression of MN1 associates with better treatment response in older patients with de novo cytogenetically normal acute myeloid leukemia.

M. Caligiuri, C. Bloomfield, M. Radmacher, 2011, Blood.

Mutations of the Wilms tumor 1 gene (WT1) in older patients with primary cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.

Guido Marcucci, Heiko Becker, Sebastian Schwind, 2010, Blood.

Corosolic acid reduces NSCLC cell proliferation, invasion, and chemoresistance via inducing mitochondrial and liposomal oxidative stress

Yue-zhong Wu, Xiyu Liu, Gang Huang, 2021 .

Identification and Targeting of the Developmental Blockade in Extranodal Natural Killer/T-cell Lymphoma.

M. Caligiuri, Y. Natkunam, Yue-zhong Wu, 2022, Blood cancer discovery.

Prognostic Utility of the European LeukemiaNet (ELN) Genetic-Risk Classification in Adults with De Novo Acute Myeloid Leukemia (AML): A Study of 1,550 Patients (Pts)

C. Bloomfield, Yue-zhong Wu, K. Metzeler, 2011 .

miR-3151 Interplays With its Host Gene BAALC and Independently Impacts on Outcome of Older Patients With Cytogenetically Normal Acute Myeloid Leukemia by Direct Deregulation of TP53

M. Caligiuri, C. Bloomfield, M. Radmacher, 2014 .

myeloid leukemia in acute microRNA-181a up-regulates expression of the antileukemic -p30 protein α Lenalidomide-mediated enhanced translation of C/EBP

C. Bloomfield, J. Byrd, L. J. Lee, 2013 .

Ramasamy myeloid leukemia in acute microRNA-181 a upregulates expression of the antileukemic-p 30 protein α Lenalidomide-mediated enhanced translation of C / EBP

Wu, Krzysztof, Santhanam, 2012 .

Pan-cancer analysis of nemo-like kinase (NLK) expression convergence to pancreatic adenocarcinoma that has diagnostic, prognostic and treatment value

Yue-zhong Wu, Yu-cai Fu, Hai-xing Song, 2021 .

Pharmacological targeting of miR-155 via the NEDD8-activating enzyme inhibitor MLN4924 (Pevonedistat) in FLT3-ITD acute myeloid leukemia

M. Caligiuri, C. Bloomfield, L. J. Lee, 2015, Leukemia.

Mutations In the Tet Oncogene Family Member 2 (TET2) Gene Refine the New European LeukemiaNet Risk Classification of Primary, Cytogenetically Normal Acute Myeloid Leukemia (CN-AML) In Adults: A Cancer and Leukemia Group B (CALGB) Study

M. Caligiuri, C. Bloomfield, M. Radmacher, 2010 .

Global DNA methylation profiling reveals silencing of a secreted form of Epha7 in mouse and human germinal center B-cell lymphomas

Yue-zhong Wu, C. Plass, M. Teitell, 2007, Oncogene.

TET2 mutations improve the new European LeukemiaNet risk classification of acute myeloid leukemia: a Cancer and Leukemia Group B study.

M. Caligiuri, C. Bloomfield, M. Radmacher, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations.

M. Caligiuri, C. Bloomfield, Yue-zhong Wu, 2013, Blood.

Lenalidomide-mediated enhanced translation of C/EBPα-p30 protein up-regulates expression of the antileukemic microRNA-181a in acute myeloid leukemia.

M. Caligiuri, C. Bloomfield, J. Byrd, 2013, Blood.

ASXL1 mutations identify a high-risk subgroup of older patients with primary cytogenetically normal AML within the ELN Favorable genetic category.

M. Caligiuri, C. Bloomfield, M. Radmacher, 2011, Blood.

Epigenetics meets genetics in acute myeloid leukemia: clinical impact of a novel seven-gene score.

M. Caligiuri, C. Bloomfield, J. Byrd, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

From The Cover : Epigenetic differences arise during the lifetime of monozygotic twins

T. Spector, E. Carlsson, M. Fraga, 2005 .

M. Caligiuri, C. Bloomfield, M. Radmacher, 2010, Blood.

Evidence of MicroRNA-29b and Sp1/NFκB-HDAC Regulatory Network for KIT Expression in KIT-Driven Acute Myeloid Leukemia (AML): Biologic and Therapeutic Implications.

M. Caligiuri, J. Byrd, Yue-zhong Wu, 2009 .